Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
82 hedge funds and large institutions have $93.2M invested in Applied Genetic Technologies Corporation in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 7 closing their positions.
229% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 7
217% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 12
84% more call options, than puts
Call options by funds: $5.62M | Put options by funds: $3.06M
63% more capital invested
Capital invested by funds: $57.2M → $93.2M (+$36M)
24% more funds holding
Funds holding: 66 → 82 (+16)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.52M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.67M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.96M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.97M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.46M |
| 2 |
Renaissance Technologies
New York
|
-$2.18M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.34M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.14M |
| 5 |
Two Sigma Investments
New York
|
-$723K |
AGTC Hedge Fund Activity: Q1 2021 in Review
82 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2021, worth a combined $93.2M — up 63% from $57.2M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AGTC positions and 7 closed out — a net gain of 16 holders — while 38 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $6.52M. The largest seller was DAFNA Capital Management, cutting an estimated $2.46M.
- 82 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2021, up from 66 in Q4 2020.
- Funds reported $93.2M of Applied Genetic Technologies Corporation stock for Q1 2021, up 63% quarter-over-quarter.
- 23 funds opened new Applied Genetic Technologies Corporation positions in Q1 2021 and 7 closed out, a net change of +16 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q1 2021 was BlackRock, an estimated $6.52M added.
- The largest Applied Genetic Technologies Corporation seller in Q1 2021 was DAFNA Capital Management, an estimated $2.46M sold.
Based on aggregated 13F filings for Q1 2021.